Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Rydelius

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Brain and Behavior|July 11, 2023
Tumoral parkinsonism-Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatmentGustav Cedergren Weber, Jonathan Timpka, Anna Rydelius, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 4, 2018
Evaluation of reproducibility in MRI quantitative volumetric assessment and its role in the prediction of overall survival and progression-free survival in glioblastomaAdam Blomstergren, Anna Rydelius, Kasim Abul-Kasim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 6, 2006
Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cellsAnna Edqvist, Johan Rebetz, Marcus Järås, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2020
Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapyAnna Rydelius, Jimmy Lätt, Sara Kinhult, et al.
Frontiers in Neuroscience|May 9, 2022
Separating Glioma Hyperintensities From White Matter by Diffusion-Weighted Imaging With Spherical Tensor EncodingJan Brabec, Faris Durmo, Filip Szczepankiewicz, et al.
Acta Oncologica (Stockholm, Sweden)|March 11, 2022
Diffusion tensor imaging in glioblastoma patients treated with volumetric modulated arc radiotherapy: a longitudinal studyAnna Rydelius, Björn Lampinen, Andreas Rundcrantz, et al.
Trials|March 14, 2025
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trialErik Ehinger, Anna Darabi, Edward Visse, et al.
Plos One|December 29, 2020
Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomasFaris Durmo, Anna Rydhög, Frederik Testud, et al.
Tomography (Ann Arbor, Mich.)|June 25, 2025
Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade GliomaFaris Durmo, Jimmy Lätt, Anna Rydelius, et al.
Frontiers in Neuroscience|January 1, 2026
Noninvasive MGMT-promotor methylation prediction in high grade gliomas using conventional MRI and deep learning-based segmentationsEdin Zahirovic, Tim Salomonsson, Malte Knutsson, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Brain and Behavior|July 11, 2023
Tumoral parkinsonism-Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatmentGustav Cedergren Weber, Jonathan Timpka, Anna Rydelius, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 4, 2018
Evaluation of reproducibility in MRI quantitative volumetric assessment and its role in the prediction of overall survival and progression-free survival in glioblastomaAdam Blomstergren, Anna Rydelius, Kasim Abul-Kasim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 6, 2006
Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cellsAnna Edqvist, Johan Rebetz, Marcus Järås, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2020
Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapyAnna Rydelius, Jimmy Lätt, Sara Kinhult, et al.
Frontiers in Neuroscience|May 9, 2022
Separating Glioma Hyperintensities From White Matter by Diffusion-Weighted Imaging With Spherical Tensor EncodingJan Brabec, Faris Durmo, Filip Szczepankiewicz, et al.
Acta Oncologica (Stockholm, Sweden)|March 11, 2022
Diffusion tensor imaging in glioblastoma patients treated with volumetric modulated arc radiotherapy: a longitudinal studyAnna Rydelius, Björn Lampinen, Andreas Rundcrantz, et al.
Trials|March 14, 2025
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trialErik Ehinger, Anna Darabi, Edward Visse, et al.
Plos One|December 29, 2020
Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomasFaris Durmo, Anna Rydhög, Frederik Testud, et al.
Tomography (Ann Arbor, Mich.)|June 25, 2025
Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade GliomaFaris Durmo, Jimmy Lätt, Anna Rydelius, et al.
Frontiers in Neuroscience|January 1, 2026
Noninvasive MGMT-promotor methylation prediction in high grade gliomas using conventional MRI and deep learning-based segmentationsEdin Zahirovic, Tim Salomonsson, Malte Knutsson, et al.
Pageof 2